Prognostic Value and Clinicopathological Features of MicroRNA-206 in Various Cancers: A Meta-Analysis

Table 2

Subgroup analysis for OS in patients with low miR-206 expression.

Stratified analysis	No. of studies	No. of patients	value	Heterogeneity
				(%)	value	Model
Cancer type
GC	3	468	≤0.001	0	0.371	Fixed
CRC	2	153	≤0.001	0	0.359	Fixed
CC	3	163	≤0.001	43.5	0.17	Fixed
RCC	3	174	0.912	87.6	≤0.001	Random
Others	8	1000	0.003	85.4	≤0.001	Random
Analysis type
Univariate analysis	8	891	0.149	85.9	≤0.001	Random
Multivariate analysis	11	1067	≤0.001	33	0.135	Fixed
Race
Caucasian	2	187	0.686	92.4	≤0.001	Random
Asian	17	1771	≤0.001	73.8	≤0.001	Random
Sample
Tissue	13	1434	≤0.001	74.8	≤0.001	Random
Serum	6	524	0.068	83	≤0.001	Random
Source of HR
Reported	10	1034	≤0.001	54.3	0.02	Random
SC	9	924	0.105	77	≤0.001	Random
Sample size
≥100	7	1185	0.006	81.6	≤0.001	Random
<100	12	773	≤0.001	71.7	≤0.001	Random